3654 results for «278»
3654 results
How to optimise the lifetime management of TAVI patients with long-life expectancy?
18 Feb 2023 – From PCR Tokyo Valves 2023
This session addresses three essential elements of a successful TAVI procedure: the impact of valve design on long-term durability, how to mitigate the risk of paravalvular leakage, and the importance of the possibility for coronary access after TAVI.
Remaining unmet needs and strategies in TAVI
19 Feb 2023 – From PCR Tokyo Valves 2023
This session focuses on valve design and durability performance in TAVI for patients with aortic stenosis, and the way it impacts future patient outcomes.
How should I treat a patient with STEMI - A patient's journey
04 Mar 2023 – From AfricaPCR 2023
The case presented in this session is that of a 39-year-old mother and housewife, diabetic for 5 years, who was transferred to the hub for primary PCI and found to have an acute inferior STEMI: follow her journey and the discussions around her treatment management.
Intervention makes a difference
04 Mar 2023 – From AfricaPCR 2023
This AfricaPCR 2023 session includes presentations of 5 cases highlighting the importance of percutaneous interventions, which often have a considerable impact on the patients who undergo them.
Coronary clinical cases - session 3
04 Mar 2023 – From AfricaPCR 2023
Among the 6 presentations offered in this AfricaPCR 2023 session, find out more about a multivessel PCI and tight aortic stenosis, the case of a 6-year-old boy with HTN and dilated cardiomyopathy, a hybrid SVG calcium modification, and rare complications in a TAVI case.
Matching patient to TAVI prosthesis - Is there a better way?
04 Mar 2023 – From AfricaPCR 2023
In this AfricaPCR 2023 session, analyse several complex TAVI cases and explore why and how THV design elements should help optimise TAVI clinical outcomes.
AfricaPCR 2023: Opening Ceremony
03 Mar 2023 – From AfricaPCR 2023
After 3 years without a physical Course, it is with great pleasure that the speakers open this new edition of AfricaPCR. They begin by recalling the values of this Course and presenting its Directors, then they unfold the programme by underlining the strong points and also...
AfricaPCR 2023: Closing Ceremony
04 Mar 2023 – From AfricaPCR 2023
Beyond all the thanks that should naturally be expressed at the time of closing this new edition of AfricaPCR, this closing ceremony is also an opportunity to remind that the contents of this course remain available on our platforms and social networks, and that the appointment...
A randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons for treatment of calcified and refractory coronary lesions - The VICTORY trial
27 Oct 2025
Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.
Author
Impella percutaneous ventricular assist device malrotation in social media: a call to action
20 Apr 2023
The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications.
Author
Author
Author
Author
Author
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
Ivus or angiography guidance for PCI in complex coronary bifurcation lesions (DKCRUSH-VIII)
31 Mar 2026
Nicola Ryan provides her take on DKCRUSH-VIII, a randomised controlled trial comparing IVUS versus angiography guidance for PCI, predominantly using the DKCRUSH technique in patients with complex bifurcation lesions, as presented by Shaoliang Chen at ACC.26 in New Orleans.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
